The European Agency for the Evaluation of Medicinal Products Veterinary Medicines Evaluation Unit EMEA/CVMP/315/98 - FINAL COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS NOTE FOR GUIDANCE: DEVELOPMENT PHARMACEUTICS FOR VETERINARY MEDICINAL PRODUCTS RELEASED FOR CONSULTATION BY CVMP
ثبت نشده
چکیده
منابع مشابه
Guideline on setting health based exposure limits for use in risk identification in the manufacture of different medicinal products in shared facilities
An agency of the European Union Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5555 Send a question via our website www.ema.europa.eu/contact © European Medicines Agency, 2014. Reproduction is authorised provided the source is acknowledged. 20 November 2014 EMA/CHMP/ CVMP/ SWP/169430/2012 Committee for Medicinal Products for Human Use (CHMP) Committee for Medicinal Products for Veterina...
متن کاملGuideline on process validation for finished products - information and data to be provided in regulatory submissions
Telephone +44 (0)20 7418 8400 Facsimile +44 (0)20 7418 8416 E-mail [email protected] Website www.ema.europa.eu An agency of the European Union © European Medicines Agency, 2014. Reproduction is authorised provided the source is acknowledged. 27 February 2014 EMA/CHMP/CVMP/QWP/BWP/70278/2012-Rev1 Committee for Medicinal Products for Human Use (CHMP) Committee for Medicinal Products for Veterina...
متن کاملGuideline on the principles of regulatory acceptance of 3Rs (replacement, reduction, refinement) testing approaches
An agency of the European Union Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5555 Send a question via our website www.ema.europa.eu/contact © European Medicines Agency, 2016. Reproduction is authorised provided the source is acknowledged. 15 December 2016 EMA/CHMP/CVMP/JEG-3Rs/450091/2012 Committee for Medicinal Products for Human Use (CHMP) Committee for Medicinal Products for Veter...
متن کاملRegulation of immunological veterinary medicinal products in the European Union.
Since 1990, immunological veterinary medicinal products have been covered by the pharmaceutical legislation of the European Union (EU) and, as a consequence, these products are now subject to the relevant general provisions regarding manufacturing and marketing authorization. For new veterinary immunologicals, the legislation entered into force on 1 April 1993. For products already on the marke...
متن کامل